Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
06/2013
06/26/2013CN103169968A Hydrophobic dihydroporphin photosensitizer nanometer pharmaceutic preparation based on albumin as well as preparation method and application of nanometer pharmaceutic preparation
06/25/2013US8471061 5-aminolevulinic acid salt, process for producing the same and use thereof
06/25/2013US8470294 Flexible and/or elastic brachytherapy seed or strand
06/25/2013US8469034 Stem cell targeting and activation using magnetic particles
06/19/2013EP2603238A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
06/19/2013CN103167882A Novel use of a yt cell line for the therapy of malignant diseases and viral infections and for producing interferon gamma
06/19/2013CN103157118A Composite nano-grade novel material based on cancer early-stage integrated detection, diagnoses, and treatment, and preparation method thereof
06/18/2013US8465762 Dermal application system for aminolevulinic acid-derivatives
06/13/2013WO2013083921A1 Medical or therapeutic application of a composite material of ruthenium with a nitrosyl ligand
06/13/2013WO2013054126A3 Nanocolloids for local temperature monitoring
06/13/2013US20130150649 Sensitization of tumor cells to radiation therapy through administration of endothelin agonists
06/12/2013EP2601967A1 Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids
06/12/2013EP2601219A2 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
06/12/2013CN103154030A Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
06/12/2013CN103154028A Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
06/12/2013CN103143035A Application of heteroatoms doped aqueous carbon quantum dot in preparation of photo-sensitizers for fluorescent imaging marking and photodynamic therapy (PDT)
06/12/2013CN103143015A Application of photosensitizer for treating acne
06/12/2013CN103143014A Microwave thermo-seed material with nano-core-shell structure
06/12/2013CN103143013A Photosensitive medicinal preparation containing amino poly-carboxylic acid modification tetraphenylporphyrin compound and purpose thereof
06/12/2013CN103142649A Preparation method of amylose-coated I3<->-complexed silver-coated iron composite nanoparticles
06/11/2013CA2632558C Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
06/11/2013CA2605617C Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
06/06/2013US20130142884 Cream for Applying on a Body
06/06/2013US20130142758 Novel hydroxamates as therapeutic agents
06/05/2013EP2599497A2 Porphyrazine-chemotherapeutic agents conjugates
06/05/2013EP2598169A1 An antigen specific ultrasound contrast medium, a process for the preparation thereof and its uses
06/05/2013CN103140241A An antigen specific ultrasound contrast medium, a process for the preparation thereof and its uses
06/05/2013CN103130837A Water-soluble cationic phosphorous iridium complex as well as preparation method and application thereof
06/05/2013CN103127506A Core/shell structured magnetic meso-porous biological active glass microsphere material and its preparation method
06/05/2013CN102056629B A photosensitising composition and its uses
06/04/2013CA2499469C Combined photocoagulation and photodynamic therapy
05/2013
05/30/2013WO2013078392A1 Methods and compositions involving induced senescent cells for cancer treatment
05/30/2013WO2013076516A1 1,4- dihydropyridine derivatives with hsp modulating activity
05/30/2013US20130138032 ANTICANCER AGENT DELIVERY SYSTEM USING pH-SENSITIVE METAL NANOPARTICLES
05/30/2013CA2854252A1 1,4-dihydropyridine derivatives with hsp modulating activity
05/29/2013EP2596021A2 A method of treating alzheimer's disease
05/29/2013EP2596020A2 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
05/29/2013EP2596019A2 A method of treating attention deficit hyperactivity disorder
05/29/2013EP2596018A2 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
05/29/2013EP2595658A2 A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
05/29/2013EP2595655A2 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
05/29/2013CN103124742A Pharmaceutical compositions and methods of treatment
05/29/2013CN103124741A Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
05/29/2013CN103121705A Preparation method of CuS nanoparticles, product and application thereof
05/29/2013CN103120640A Embolic agent as well as preparation method and use method thereof
05/23/2013US20130130991 Use of a peptide enhancing the ability of radiation therapy to kill cancer cells
05/23/2013US20130129799 Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation by using tumor proliferation inhibitor and low-intensity pulsed ultrasound waves
05/23/2013US20130129664 Cancer Therapy Via Selective Uptake of Specialized Nanoparticles in Cancer Cells
05/23/2013US20130129633 Multimodal nanoparticles for non-invasive bio-imaging
05/23/2013US20130129616 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
05/22/2013EP2593482A2 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
05/22/2013EP2593477A2 Pharmaceutical compositions and methods of treatment
05/22/2013EP2593474A2 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
05/22/2013EP2593140A2 A method of increasing the effect of an activated-potentiated form of an antibody
05/22/2013EP2593138A2 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
05/22/2013EP2593086A1 Lipid bilayer carrier for drugs or imaging agents
05/22/2013CN103119061A A method of treating attention deficit hyperactivity disorder
05/22/2013CN103119060A A method of treating alzheimer's disease
05/22/2013CN103118742A Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
05/22/2013CN103118707A A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
05/22/2013CN103110946A Self-temperature-control nano thermoseed material based on cell thermotherapy and preparation method thereof
05/16/2013WO2013068405A1 Composition for photodynamic diagnosis and treatment of tumors
05/16/2013US20130123781 Targeting microbubbles
05/16/2013CA2853013A1 Composition for the photodynamic diagnosis and treatment of tumours
05/15/2013EP2591804A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
05/15/2013EP2591803A1 Composition for the photodynamic diagnosis and treatment of tumours
05/15/2013EP2590714A1 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
05/15/2013CN103108657A A method of increasing the effect of an activated-potentiated form of an antibody
05/09/2013US20130116281 Multiphoton Activable Quinoline Derivatives, Their Preparation and Their Uses
05/09/2013US20130115295 Rare Earth-Doped Up-Conversion Nanoparticles for Therapeutic and Diagnostic Applications
05/09/2013US20130115133 Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums
05/08/2013EP2589969A1 Physical carrier of biologically active frequencies
05/08/2013DE112011102397T5 Pharmazeutische Kombinationszusammensetzungen und Verfahren zur Behandlung von Schwindel, Kinetose und vegetativ-vaskulärer Dystonie A pharmaceutical combination compositions and methods for treating vertigo, motion sickness and vegetative-vascular dystonia
05/08/2013CN103096927A Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
05/08/2013CN103083133A Fundus disease laser photo-thermal treatment system based on gold nanorods
05/08/2013CN102552907B Application of non-surrounding displaced phthalocyanine zinc in preparing sonosensitizer
05/07/2013CA2746516C Non-polar photosensitizer formulations for photodynamic therapy
05/07/2013CA2581632C Biodegradable cationic polymers
05/07/2013CA2564197C Activatable particles, preparations and uses
05/02/2013DE112011102396T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Diabetes und metabolischen Störungen A pharmaceutical combination composition and methods for the treatment of diabetes and metabolic disorders
05/01/2013EP2586794A2 Manufacture, Compositions and Uses of Coagulationfactor VIIA Modulator
05/01/2013EP2585111A1 Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
05/01/2013CN103073553A Water-soluble naphthalocyanine base compound, preparation method and application of compound as photosensitizer
04/2013
04/25/2013WO2012010974A8 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
04/25/2013US20130102953 Nano Mixed Metal Oxide Thin Film Photocatalyst Consisting Of Titanium, Indium and Tin
04/25/2013US20130101616 Compositions of botanical extracts for cancer therapy
04/25/2013DE112011102362T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit neurodegenerativen Erkrankungen in Verbindung stehen A pharmaceutical combination composition and methods for treating diseases or conditions associated with neurodegenerative diseases in connection
04/25/2013DE112011102358T5 Verfahren zur Erhöhung der Wirkung einer aktivierten-potenzierten Form eines Antikörpers A method for increasing the effect of an activated-potentiated form of an antibody
04/25/2013DE112011102355T5 Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von funktionellen Erkrankungen oder Zuständen des Gastrointestinaltraktes A pharmaceutical combination composition and methods for the treatment of functional disorders or conditions of the gastrointestinal tract
04/24/2013EP2583690A1 Liposome including elastin-like polypeptide hydrophobic group conjugate, chemosensitizer and anticancer agent and use thereof
04/24/2013EP2583689A1 Liposome including elastin-like polypeptides and use thereof
04/24/2013EP2582672A1 X-ray and gamma-photon activable organic compounds, their preparation and their uses
04/24/2013CN103059184A Amino porphyrin- poly (N-isopropylacrylamide) europium coordination compound and preparation method thereof
04/24/2013CN103058642A Nanoscale hot seed material for microwave tumor thermotherapy and preparation method thereof
04/24/2013CN103055312A Application of ferroferric oxide as photo-thermal sensitive material
04/23/2013CA2562170C 5-aminolevulinic acid salt, process for producing the same and use thereof
04/23/2013CA2436245C Medicament for protection in radiotherapy
04/18/2013WO2013054138A1 Heat patches
04/18/2013WO2013054126A2 Nanocolloids for local temperature monitoring
04/18/2013WO2013053927A1 Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 95